AU2001286503A1 - Method of treating alzheimer's disease with cell therapy - Google Patents

Method of treating alzheimer's disease with cell therapy

Info

Publication number
AU2001286503A1
AU2001286503A1 AU2001286503A AU8650301A AU2001286503A1 AU 2001286503 A1 AU2001286503 A1 AU 2001286503A1 AU 2001286503 A AU2001286503 A AU 2001286503A AU 8650301 A AU8650301 A AU 8650301A AU 2001286503 A1 AU2001286503 A1 AU 2001286503A1
Authority
AU
Australia
Prior art keywords
disease
cell therapy
treating alzheimer
alzheimer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286503A
Inventor
Karen S. Aboody
Mo Daadi
Jean F. Loring
Gary L. Snable
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Layton Bioscience Inc
Original Assignee
Layton Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Layton Bioscience Inc filed Critical Layton Bioscience Inc
Publication of AU2001286503A1 publication Critical patent/AU2001286503A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0312—Animal model for Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
AU2001286503A 2000-08-14 2001-08-14 Method of treating alzheimer's disease with cell therapy Abandoned AU2001286503A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22531700P 2000-08-14 2000-08-14
US60225317 2000-08-14
PCT/US2001/025629 WO2002014474A2 (en) 2000-08-14 2001-08-14 Method of treating alzheimer's disease with cell therapy

Publications (1)

Publication Number Publication Date
AU2001286503A1 true AU2001286503A1 (en) 2002-02-25

Family

ID=22844404

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001284969A Abandoned AU2001284969A1 (en) 2000-08-14 2001-08-14 A novel animal model of alzheimer's disease using genetically altered stem cells
AU2001286503A Abandoned AU2001286503A1 (en) 2000-08-14 2001-08-14 Method of treating alzheimer's disease with cell therapy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001284969A Abandoned AU2001284969A1 (en) 2000-08-14 2001-08-14 A novel animal model of alzheimer's disease using genetically altered stem cells

Country Status (2)

Country Link
AU (2) AU2001284969A1 (en)
WO (2) WO2002014474A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9802992B2 (en) 2005-12-06 2017-10-31 Tokyo Metropolitan Institute Of Medical Science Cell into which protein, which can serve as polymerization nucleus of protein polymer, or polymer thereof is introduced, and method for production of the cell

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750376A (en) * 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny

Also Published As

Publication number Publication date
AU2001284969A1 (en) 2002-02-25
WO2002013837A1 (en) 2002-02-21
WO2002014474A3 (en) 2002-06-20
WO2002014474A2 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU2001249881A1 (en) Method of treating the heart
AU2830097A (en) Therapeutic method for treatment of alzheimer's disease
AU2001294604A1 (en) Improved radiation therapy treatment method
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU2001273132A1 (en) Compounds to treat alzheimer's disease
AU2003220096A1 (en) Methods for alzheimer's disease treatment and cognitive enhancement
AU1407399A (en) Treatment for alzheimer's disease
AU2002306848A1 (en) Methods of treating alzheimer's disease with piperidin derivates
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
AU2002319615A1 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2002246490A1 (en) Method of treating parkinson's disease
AU2002212471A1 (en) Peptides for use in the treatment of alzheimer's disease
AU2000258352A1 (en) Acupuncture points stimulation for treating various diseases
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
AU2001236713A1 (en) Methods for treatment of lysosomal storage diseases
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU1405899A (en) Treatment for alzheimer's disease
AU1133901A (en) Method of treating metabolic disorders
AU2003237657A1 (en) Means and methods for improved treatment using "setrones"
AU2002312667A1 (en) Individualization of therapy with alzheimer's disease agents
GB0011408D0 (en) Therapeutic combination for treating Alzheimer's Disease
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases